Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

BACKGROUND Liposuction has been proposed as a potential treatment for the metabolic complications of obesity. We evaluated the effect of large-volume abdominal liposuction on metabolic risk factors for coronary heart disease in women with abdominal obesity. METHODS We evaluated the insulin sensitivity of liver, skeletal muscle, and adipose tissue (with a euglycemic-hyperinsulinemic clamp procedure and isotope-tracer infusions) as well as levels of inflammatory mediators and other risk factors for coronary heart disease in 15 obese women before and 10 to 12 weeks after abdominal liposuction. Eight of the women had normal glucose tolerance (mean [+/-SD] body-mass index, 35.1+/-2.4), and seven had type 2 diabetes (body-mass index, 39.9+/-5.6). RESULTS Liposuction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes; those with normal oral glucose tolerance lost 9.1+/-3.7 kg of fat (18+/-3 percent decrease in total fat, P=0.002), and those with type 2 diabetes lost 10.5+/-3.3 kg of fat (19+/-2 percent decrease in total fat, P<0.001). Liposuction did not significantly alter the insulin sensitivity of muscle, liver, or adipose tissue (assessed by the stimulation of glucose disposal, the suppression of glucose production, and the suppression of lipolysis, respectively); did not significantly alter plasma concentrations of C-reactive protein, interleukin-6, tumor necrosis factor alpha, and adiponectin; and did not significantly affect other risk factors for coronary heart disease (blood pressure and plasma glucose, insulin, and lipid concentrations) in either group. CONCLUSIONS Abdominal liposuction does not significantly improve obesity-associated metabolic abnormalities. Decreasing adipose tissue mass alone will not achieve the metabolic benefits of weight loss.

[1]  C. Bogardus,et al.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance , 2000, Diabetologia.

[2]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[3]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[4]  S. Grundy,et al.  Relationships of generalized and regional adiposity to insulin sensitivity in men. , 1995, The Journal of clinical investigation.

[5]  T. Wadden,et al.  AGA technical review on obesity. , 2002, Gastroenterology.

[6]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[7]  A. Dattilo,et al.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. , 1992, The American journal of clinical nutrition.

[8]  Simon C Watkins,et al.  Intramuscular lipid content is increased in obesity and decreased by weight loss. , 2000, Metabolism: clinical and experimental.

[9]  F. Ginsberg-Fellner,et al.  Effect of Weight Reduction on in Vitro Adipose Tissue Lipolysis and Cellularity in Obese Adolescents and Adults , 1972, Diabetes.

[10]  S. Klein,et al.  Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. , 1996, The American journal of physiology.

[11]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[12]  P. Cryer,et al.  Effect of short-term fasting on lipid kinetics in lean and obese women. , 1999, American journal of physiology. Endocrinology and metabolism.

[13]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[14]  Rod J. Rohrich,et al.  Safety considerations and fluid resuscitation in liposuction: an analysis of 53 consecutive patients. , 1998, Plastic and reconstructive surgery.

[15]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[16]  D. Hudson,et al.  Metabolic response to localized surgical fat removal in nonobese women , 1991, Aesthetic plastic surgery.

[17]  T. Wadden,et al.  Tumor Necrosis Factor-α in Sera of Obese Patients: Fall with Weight Loss , 1998 .

[18]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[19]  J. Tuomilehto,et al.  Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. , 2003, Diabetes.

[20]  E. Bulan,et al.  Improvements in cardiovascular risk profile with large-volume liposuction: a pilot study. , 2001, Plastic and reconstructive surgery.

[21]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  R. Ahima,et al.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[23]  A. Häkkinen,et al.  Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. , 2003, Diabetes.

[24]  J. Horowitz,et al.  Whole-body and adipose tissue glucose metabolism in response to short-term fasting in lean and obese women. , 2001, The American journal of clinical nutrition.

[25]  N. Milas,et al.  Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II , 2001, Annals of Internal Medicine.

[26]  Berntorp,et al.  Liposuction in Dercum's disease: impact on haemostatic factors associated with cardiovascular disease and insulin sensitivity , 1998, Journal of internal medicine.

[27]  J. Kral,et al.  The impact of liposuction on body fat. , 1998, Plastic and reconstructive surgery.

[28]  Ballor Dl,et al.  Exercise-training enhances fat-free mass preservation during diet-induced weight loss: a meta-analytical finding. , 1994 .

[29]  R. Schwartz,et al.  Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[31]  S. Kihara,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[32]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[33]  K. Birkeland,et al.  Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females , 1995, Aesthetic Plastic Surgery.

[34]  E. Martínez-Abundis,et al.  The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[35]  R. Marfella,et al.  Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year , 2002, Circulation.

[36]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[37]  G. Commons,et al.  Large-volume liposuction: a review of 631 consecutive cases over 12 years. , 2001, Plastic and reconstructive surgery.